PPI Side Effects: Fearmongering or Legitimate Warning?

Millions of people rely on proton pump inhibitors to calm heartburn and heal ulcers. But when researchers warn about possible PPI side effects, are they offering prudent advice, or just fearmongering? As new studies continue to emerge, the safety of these widely used acid-suppressing drugs is once again under scrutiny.

The safety question surfaced recently in a message from a reader whose physician dismissed concerns about proton pump inhibitors (PPIs) as exaggerated. Yet the scientific literature tells a much more complicated story.

Drugs such as omeprazole (Prilosec), esomeprazole (Nexium) and lansoprazole (Prevacid) were once considered extraordinarily safe. They became so popular that the FDA eventually approved several for over-the-counter sale. After decades of widespread use, however, researchers continue to uncover new and sometimes troubling PPI side effects.

A Question From Our Newspaper Column:

This question appeared in our nationally syndicated People’s Pharmacy newspaper column starting on March 9, 2026:

Q. I have read in your column that long-term use of proton pump inhibitors for reflux can cause a bunch of serious health problems. My doctor said that was fearmongering and not to worry. What is the story on PPIs?

A. PPIs such as esomeprazole (Nexium), lansoprazole (Prevacid) and omeprazole (Prilosec) have been extremely popular for decades to heal ulcers and control heartburn.

Long-term use, however, may contribute to chronic kidney disease (Cureus, Jan. 24, 2026). Other complications can include low calcium and magnesium levels. Such mineral imbalances might increase the chance of drug-induced osteoporosis (Journal of Clinical Medicine, Jan. 26, 2026).

PPIs Are Among the Most Popular Drugs in America

Millions of people take proton pump inhibitors every day. Doctors write more than 80 million prescriptions annually, and many more people buy OTC versions such as Prilosec OTC, Nexium 24HR and Prevacid 24HR.

You may not recognize the generic names:

• dexlansoprazole
• esomeprazole
• lansoprazole
• omeprazole
• pantoprazole
• rabeprazole

But many of the brand names—Aciphex, Dexilant, Nexium, Prevacid, Prilosec and Protonix—are almost household words.

Initially, doctors believed these drugs had very few, if any, side effects. Today, that assumption is being reconsidered.

Serious PPI Side Effects Keep Accumulating

Large epidemiological studies continue to link prolonged PPI use to a surprising range of complications. One study involving more than 200,000 participants in the Nurses’ Health Study cohorts found that people taking PPIs regularly were 24% more likely to develop type 2 diabetes (Gut, Sept. 28, 2020).

Researchers noted that long-term PPI use has previously been associated with:

• bone fractures
• chronic kidney disease
• gastrointestinal infections
• changes in the gut microbiome

Because millions of people take PPIs for years, even modest risks could affect a large number of patients.

Stroke and Heart Attack Risk and the Dose-Response Effect

Another unexpected complication involves serious PPI side effects: strokes and heart attacks.

Danish investigators analyzed medical records of ~215,000 adults over 5.8 years (Journal of Internal Medicine, Oct. 12, 2017). Current use of PPIs was associated with a 13% increased risk of ischemic (clotting) stroke and a 31% increased risk of heart attack (MI or myocardial infarction).

The authors note that:

“These associations are consistent with previous findings from other observational studies in low-risk general populations.”

Even more concerning was a classic pharmacological pattern called a dose-response curve: the higher the dose, the greater the risk.

These Danish researchers report:

“Additionally, we found a dose–response relationship between PPI use and both stroke and MI. Although the lowest dose of PPI was not associated with fatal and nonfatal ischemic stroke and MI, a stepwise dose-dependent increase in associated risk was observed (particularly for MI). Short-term PPI use was not significantly associated with either outcome…For the baseline treatment analysis, long-term PPI use was significantly associated with 29% higher risk of ischemic stroke and 36% higher risk MI compared to nonusers.”

When side effects increase as dosage rises, researchers take notice. That’s because the likelihood this is a real cause and effect relationship is reinforced by such data.

A Possible Cardiovascular Mechanism

Scientists have proposed several biological explanations.

PPIs inhibit the stomach’s proton pump enzyme to suppress acid production. Unfortunately, they may also interfere with other enzymes that play important roles in cardiovascular health.

One example involves the enzyme DDAH, which influences nitric oxide production (Pharmacotherapy, Feb. 2021).

Nitric oxide helps blood vessels relax and function normally. When its production declines, blood vessels may become stiff or dysfunctional—conditions associated with heart disease and stroke.

This phenomenon illustrates what scientists sometimes call the law of unintended consequences.

PPI Side Effects and Liver Disease

Another concern involves the gut-liver connection.

Research suggests that suppressing stomach acid alters microbial populations in the digestive tract. Certain bacteria such as Enterococcus can flourish and migrate to the liver, potentially triggering inflammation.

A study exploring this mechanism appeared in Nature Communications (Oct. 10, 2017).

PPIs and the Gut Microbiome

Dutch researchers also reported that PPI users show significant changes in their intestinal microbiome (Gut, May 2016).

The authors conclude:

“Our findings describe a significant impact of PPIs on the gut microbiome and should caution over-use of PPIs, and warrant further investigation into the mechanisms and their clinical consequences.”

These microbial shifts may explain why people taking PPIs appear to have increased susceptibility to infections such as Clostridium difficile. Newer research also confirms that proton pump inhibitors “alter gut microbiota” (Gut, June 6, 2024).

Drug-Resistant Bacteria

Another concern involves multidrug-resistant organisms.

A meta-analysis of 26 observational studies including nearly 30,000 people found that PPI users were more likely to harbor resistant microbes such as MRSA and vancomycin-resistant enterococci (JAMA Internal Medicine, Feb. 24, 2020).

The authors conclude:

“This systematic review and meta-analysis showed that the use of acid suppressants (mainly PPIs or H₂RAs [histamine antagonists]) is associated with a 75% increase in the odds of intestinal MDRO [multidrug-resistant microorganisms] colonization, both in the community and in the health care setting.”

In other words, people taking PPIs may harbor pathogens that are resistant to antibiotics. This could have implications not only for individual patients but also for public health.

PPI Side Effects and Kidney Disease!

Kidney complications have been among the most frequently reported PPI side effects.

Long-term use has been associated with acute kidney injury and chronic kidney disease in several observational studies.

A review published in Cureus (Jan. 24, 2026) concluded:

“Notably, our review found a robust association between PPI use and incident CKD [chronic kidney disease]. A substantial body of prior research strengthens these findings.”

Are PPIs Linked to Premature Death?

Some researchers are asking an even more troubling question: could long-term PPI use increase the risk of premature death?

A study of more than 19,000 adults with type 2 diabetes using UK Biobank data found that PPI users had higher risks of:

• coronary artery disease
• heart attack
• heart failure
• all-cause mortality

(Journal of Clinical Endocrinology and Metabolism, May 17, 2023).

Another study in the journal Drugs & Aging, March, 2024 concluded:

“Our findings confirmed an increased risk of CV [cardiovascular] events and all-cause mortality in a large population of older adults with DM [diabetes mellitus] exposed to PPIs.”

Other Potential PPI Side Effects

Researchers have linked prolonged PPI use to a variety of additional complications:

• pneumonia and Clostridium difficile infections
• heart attacks and vascular calcification
• dementia or Alzheimer’s disease
• vitamin and mineral deficiencies (calcium, magnesium, B12, zinc)
• osteoporosis and fractures
• blood disorders such as anemia

Not every study proves cause and effect, but the pattern of findings has raised concern among many researchers.

When PPIs Are Medically Necessary

Despite all these warnings, PPIs can be extremely valuable medications.

They are often essential for:

• healing stomach ulcers
• preventing bleeding in high-risk patients
• treating Zollinger-Ellison syndrome, a rare disorder that causes extreme acid production

The real question may not be whether PPIs work—they clearly do—but whether they are overused and taken for too long.

Stopping PPIs Can Be Difficult

People who stop PPIs abruptly may experience rebound hyperacidity, a surge in stomach acid production that causes severe heartburn.

One reader described his experience:

“Even a short period on PPIs can set you up for withdrawal symptoms. I was prescribed pantoprazole for 30 days… I rarely had heartburn before, but I had it for a month after ending the pantoprazole.”

For that reason, never stop a PPI suddenly without medical supervision.

Should the FDA Reconsider OTC PPIs?

Imagine the FDA’s outrage if a dietary supplement or herb were linked to heart attacks, strokes, kidney or liver disease. Doctors would insist that such a scary product be removed from health food stores immediately! There almost assuredly would be immediate regulatory action.

And yet the FDA seems uninterested in alerting the public to such adverse reactions. Remember, PPIs are 1) readily available in pharmacies, supermarkets, gas stations, quickie marts and other convenience stores and 2) it is not easy to stop PPIs after you have taken them for several weeks.

Do you think the FDA should do anything about the growing list of serious PPI side effects? We would love to get your feedback in the comment section below. We will share your comment with key executives at the Food and Drug Administration. We hope that they will take your concerns seriously.

Want to learn more about effective ways to deal with indigestion or other gastrointestinal complications such as constipation or diarrhea? Our eGuide to Overcoming Digestive Disorders is available in our Health eGuides section. Please share this article with friends and family by scrolling to the top of this article and clicking on one of the icons for email or social media. Thank you for supporting our work.